Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice-brief report

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 10, 2009, Pages 1478-1480

  Ovchinnikova, Olga ^a   Gylfe, Åsa ^b   Bailey, Leslie ^b   Nordström, Anna ^b   Rudling, Mats ^b   Jung, Christian ^a   Bergström, Sven ^b   Waldenström, Anders ^b   Hansson, Göran K ^a   Nordström, Peter ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Collagen; Fibrous cap; Mice; Osteoprotegerin

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; COLLAGEN FIBER; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE; RECOMBINANT CYTOKINE; RECOMBINANT OSTEOPROTEGERIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROGENESIS; FIBROSIS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SMOOTH MUSCLE FIBER; SUBENDOTHELIUM; UPREGULATION; VASCULITIS; ANIMAL; ATHEROSCLEROSIS; BONE DENSITY; C57BL MOUSE; DRUG EFFECT; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BONE DENSITY; COLLAGEN; FEMALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; OSTEOPROTEGERIN; PROTEIN-LYSINE 6-OXIDASE;

EID: 70349568748     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.188185     Document Type: Article

References (9)

1. Simonet WS, Lacey DL, Dunstan CR, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309-319.
2. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142:5050-5055.
3. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol. 2006;26:857-863.
4. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-1268.
5. Morony S, Tintut Y, Zhang Z, Cattley RC, Van G, Dwyer D, Stolina M, Kostenuik PJ, Demer LL. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation. 2008;117: 411-420.
6. Pritzker LB, Scatena M, Giachelli CM. The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. Mol Biol Cell. 2004;15:2834-2841.
7. Bennett BJ, Scatena M, Kirk EA, Rattazzi M, Varon RM, Averill M, Schwartz SM, Giachelli CM, Rosenfeld ME. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol. 2006;26:2117-2124.
8. Rodriguez C, Martinez-Gonzalez J, Raposo B, Alcudia JF, Guadall A, Badimon L. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res. 2008;79:7-13.
9. Ovchinnikova O, Robertson AK, Wagsater D, Folco EJ, Hyry M, Myl-lyharju J, Eriksson P, Libby P, Hansson GK. T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am J Pathol. 2009;174:693-700.